| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Capricor Therapeutics, Inc.'s insiders have reduced their positions by a net 50,000 shares worth roughly $1.5M.
CAPR sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 80.0K | $314.4K | - | |
| Dir | 50.0K | $196.5K | - | |
| CEO | 50.0K | $196.5K | - | |
| CFO | 35.3K | $138.8K | - | |
| VP | 31.3K | $122.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2016 | Gershell Leland | Chief Financial Officer | Buy | 2,100 | $2.40 | $5,040.00 | New | |
| Mar 16, 2016 | Krasney Karen | EVP, General Counsel | Buy | 4,060 | $2.40 | $9,744.00 | +57.2% | |
| Mar 16, 2016 | Marban Linda | Chief Executive Officer | Buy | 10,152 | $2.40 | $24,364.80 | +3.9% | |
| Mar 16, 2016 | Bergmann Anthony | Vice President Of Finance | Buy | 2,030 | $2.40 | $4,872.00 | New | |
| Mar 16, 2016 | Manzo Louis | Director | Buy | 100,000 | $2.40 | $240,000.00 | +352.3% | |
| Mar 16, 2016 | Grasmick Louis J | Director | Buy | 91,369 | $2.40 | $219,285.60 | +8.7% | |
| Mar 16, 2016 | Cedars Sinai Medical Center | 10% Owner | Buy | 416,666 | $2.40 | $999,998.40 | +19.2% | |
| Aug 20, 2015 | Grasmick Louis J | Director | Buy | 11,900 | $4.11 | $48,893.82 | +450.8% | |
| Aug 19, 2015 | Marban Eduardo | 10% Owner | Buy | 18,400 | $4.36 | $80,228.00 | +0.3% | |
| Aug 19, 2015 | Marban Linda | Chief Executive Officer | Buy | 18,400 | $4.36 | $80,228.00 | +0.3% |